Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015, Article ID 198612, 7 pages
Review Article

An Overview of Potential Targets for Treating Amyotrophic Lateral Sclerosis and Huntington’s Disease

Laboratório de Neurofarmacologia, Departamento de Farmacologia, Instituto de Ciências Biológicas (ICB), Universidade Federal de Minas Gerais, Campus Pampulha, 31270901 Belo Horizonte, MG, Brazil

Received 5 December 2014; Accepted 8 April 2015

Academic Editor: Eduardo Candelario-Jalil

Copyright © 2015 Caroline Zocatelli de Paula et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [3 citations]

The following is the list of published articles that have cited the current article.

  • Liyana Ahmad, Jean-Laurent Casanova, Vanessa Sancho-Shimizu, and Shen-Ying Zhang, “Human TBK1: A Gatekeeper of Neuroinflammation,” Trends in Molecular Medicine, vol. 22, no. 6, pp. 511–527, 2016. View at Publisher · View at Google Scholar
  • Sergio B. Socias, Florencia Gonzalez-Lizarraga, Cesar L. Avila, Cecilia Vera, Leonardo Acuña, Julia E. Sepulveda-Diaz, Elaine Del-Bel, Rita Raisman-Vozari, and Rosana N. Chehin, “Exploiting the therapeutic potential of ready-to-use drugs: repurposing antibiotics against amyloid aggregation in neurodegenerative diseases,” Progress in Neurobiology, 2017. View at Publisher · View at Google Scholar
  • Neha Singh, Sheekha Vijayanti, and Lekha Saha, “Targeting crosstalk between Nuclear factor (erythroid-derived 2)-like 2 and Nuclear factor kappa beta pathway by Nrf2 activator dimethyl fumarate in epileptogenesis,” International Journal of Neuroscience, pp. 1–8, 2018. View at Publisher · View at Google Scholar